Our Advisors
UNDER CONSTRUCTION
Our Advisors
Corporate Development
Privately held company. Since its inception, it has been capitalized using convertible notes, non-dilutive grants, and equity.
Professionals
OssiFi is developing best in class sclerostin small molecule inhibitors to take advantage of new opportunities to develop safer, more effective bone building therapies.
Distribution List
Sign up to keep updated on OssiFi news.
Careers
OssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation.
ABOUT US
OssiFi Therapeutics is an innovative bone-biology company operating at the intersection of therapeutics and medical devices to address significant unmet needs in neurogenic low back pain, fracture repair, and fracture prevention.